MarketMoodz
BAT to Cut ~9,000 Jobs in AI-Led Overhaul, Aiming for $793M Savings
British American Tobacco is planning to cut about 5,500 jobs and outsource roughly 3,500 roles—around 9,000 positions globally, excluding the U.S.—as part of an AI-driven restructuring aimed at slashing costs. The company says the program targets about $793 million in annualized savings by 2028, with most savings expected by 2027, a move that will reshape its cost base during a decline in traditional cigarette demand.
Key Takeaways
- BAT plans to cut roughly 5,500 jobs and outsource about 3,500 roles—around 9,000 positions affected globally (ex-U.S.), or about 20% of the workforce.
- The restructuring leans on artificial intelligence to redesign processes and operations to lower costs and boost profits.
- BAT expects approximately $793 million in annualized cost savings by 2028, with much of the benefit delivered by 2027.
- Roles moved to third parties include service-hub and tech jobs in Costa Rica, Mexico, Romania, Malaysia, Pakistan and Poland.
- BAT is shifting focus toward Vuse vapes and Velo nicotine pouches while traditional tobacco sales are forecast to fall ~2.5% this year.
People Involved
- No specific individuals mentioned
Entities Involved
- British American Tobacco (BTI)Global tobacco company implementing an AI-driven restructuring and cost-cutting program
- Philip Morris International (PM)Industry peer noted for leading position in reduced-risk products
- U.S. regulatory agencies (FDA)Regulators cited as slow to license new vape products, affecting product rollout in the U.S.
- Third‑party service providersOutsourcing partners expected to absorb about 3,500 roles
- Vuse (BAT brand)BAT's vape brand targeted for growth
- Velo (BAT brand)BAT's nicotine pouch brand targeted for growth
MarketMoodz Analysis
For investors this is a balance of risk and reward. A $793 million annualized saving materially improves operating leverage if realized, supporting margins, free cash flow and BAT’s ability to sustain dividends or buybacks. Expect near-term restructuring charges and execution risk—severance, outsourcing transition costs and potential service disruptions—that can weigh on earnings for a quarter or two before the run-rate benefit arrives (noted as largely by 2027).
The move reflects a broader industry correction. Traditional cigarette volumes are under pressure—forecast down about 2.5% this year—pushing legacy players to squeeze costs and accelerate the shift to reduced‑risk products. BAT has been trimming manufacturing capacity over the past 18–24 months, including an announced factory closure in South Africa; this latest program is a more aggressive, tech-enabled phase of that effort. BAT trails Philip Morris in some reduced-risk categories, which helps explain the urgency to reallocate capital and labor toward Vuse and Velo.
What to watch next: seek official confirmation and details in BAT’s press releases or regulatory filings, monitor guidance for restructuring charges and the timing of the projected savings (especially updates through 2027), and track regulatory developments in the U.S. that will shape product rollouts. Also watch competitors’ responses and any local pushback in countries where jobs are cut or outsourced—those factors will determine if cost savings translate into sustainable margin improvement or become a short-term headline play.
Source: Original Article